Abstract:BACKGROUND:Patients with COVID-19 caused by SARS-CoV-2 exhibit diverse clinical manifestations and severity including enteric involvement. Commensal gut bacteria can contribute to defense against potential pathogens by promoting beneficial immune interactions. Interventions targeting the gut microbiome may have systemic anti-viral effects in SARS-CoV-2 infection.SCOPE AND APPROACH:To summarise alterations of gut microbiota in patients with COVID-19 including impact of specific bacteria on disease severity, discuss current knowledge on the role of probiotics, prebiotics and dietary approaches including vitamin D in preventing and reducing disease susceptibility and review clinical studies using probiotics to target coronavirus. A literature review on SARS-CoV-2, COVID-19, gut microbiome and immunity was undertaken and relevant literature was summarised and critically examined.KEY FINDINGS AND CONCLUSIONS:Integrity of gut microbiome was perturbed in SARS-CoV-2 infections and associated with disease severity. Poor prognosis in SARS-CoV-2 infection was observed in subjects with underlying co-morbidities who had increased gut permeability and reduced gut microbiome diversity. Dietary microbes, including probiotics or selected prebiotics of Chinese origin, had anti-viral effects against other forms of coronavirus, and could positively impact host immune functions during SARS-CoV-2 infection. Numerous studies are investigating the role of probiotics in preventing and reducing susceptibility to SARS-CoV-2 infection in healthcare workers, household contacts and affected patients. An approach to strengthen intestinal barrier and lower pro-inflammatory states by adopting a more diversified diet during COVID-19 pandemic.SARS-CoV-2 infection is associated with immune dysfunction and gut microbiota alterations. Delineating mechanisms of probiotics, prebiotics and diet with anti-SARS-CoV-2 immunity present opportunities for discovery of microbial therapeutics to prevent and treat COVID-19.

The probiotic Bifidobacterium in the management of Coronavirus: A theoretical basis

Probiotics potentials in mitigating coronavirus disease (COVID-19) pandemic

IMPORTANCE OF PROBIOTICS IN THE PREVENTION AND TREATMENT OF COVID-19

Probiotics and Covid-19

Probiotics: A potential immunomodulator in COVID-19 infection management

Role of Probiotics in the Management of COVID-19: A Computational Perspective

Probiotics as Adjunctive Treatment for Patients Contracted COVID-19: Current Understanding and Future Needs

Probiotics for immunomodulation in prevention against respiratory viral infections with special emphasis on COVID-19

Effect of probiotics as an immune modulator for the management of COVID-19

Oral probiotics in coronavirus disease 2019: connecting the gut–lung axis to viral pathogenesis, inflammation, secondary infection and clinical trials

Probiotics improve symptoms of patients with COVID-19 through gut-lung axis: a systematic review and meta-analysis

The role of probiotics in coronavirus disease-19 infection in Wuhan: A retrospective study of 311 severe patients

The potential application of probiotics and prebiotics for the prevention and treatment of COVID-19

Effective Regulation of Gut Microbiota With Probiotics and Prebiotics May Prevent or Alleviate COVID-19 Through the Gut-Lung Axis

Probiotics and prebiotics: potential prevention and therapeutic target for nutritional management of COVID-19?

Immunomodulatory Effects of Probiotics on COVID-19 Infection by Targeting the Gut–Lung Axis Microbial Cross-Talk

Prophylactic effects of probiotics on respiratory viruses including COVID-19: a review

Probiotics in Prevention and Treatment of COVID-19: Current Perspective and Future Prospects

The Influence of Probiotic Lactobacilli on COVID-19 and the Microbiota

Review Article: Probiotics, Prebiotics and Dietary Approaches During COVID-19 Pandemic

Probiotics and COVID-19 – Authors' Reply